Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 51Lung Neoplasms 40Carcinoma, Non-Small-Cell Lung 28Neoplasm Metastasis 25Brain Neoplasms 23Pancreatic Neoplasms 22Lymphoma, Large B-Cell, Diffuse 22Glioma 20Breast Neoplasms 20Squamous Cell Carcinoma of Head and Neck 17Glioblastoma 17Multiple Myeloma 16Colorectal Neoplasms 14Carcinoma, Renal Cell 13Urinary Bladder Neoplasms 12Mouth Neoplasms 11Lymphoma, Mantle-Cell 11Triple Negative Breast Neoplasms 10Oropharyngeal Neoplasms 10Melanoma 10Leukemia, Lymphocytic, Chronic, B-Cell 10Carcinoma 10Ovarian Neoplasms 9Laryngeal Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Nasopharyngeal Carcinoma 8Lymphoma, Follicular 8Leukemia, Myeloid, Acute 8Lymphoma, B-Cell 7Hypopharyngeal Neoplasms 7

Interventions

Specimen Handling 1Magnetic Resonance Spectroscopy 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Castration Resistant Prostate Cancer × Magnetic Resonance Spectroscopy × Clear all
NCT05919329 2025-10-24

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

OHSU Knight Cancer Institute

Phase 4 Recruiting
80 enrolled
Genitourinary

Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡